Remote technologies for monitoring gait changes due to neurodegenerative diseases in children: Evaluation, issues, and future promiseMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
A multi-disciplinary collaboration to investigate the potential contexts of using sleep-based DHTs into clinical research and practiceMOLECULAR GENETICS AND METABOLISMIF3.52025-02-010PRE
Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A/B)ORPHANET JOURNAL OF RARE DISEASESIF3.52023-04-1732OAAI
At home enzyme replacement therapy for patients with lysosomal disorders: A single-centre experienceMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Cipaglucosidase alfa and miglustat under the Early Access to Medicines Scheme (EAMS): A single centre experienceMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Development of a patient-reported data collection system for Niemann-Pick diseaseMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR)ORPHANET JOURNAL OF RARE DISEASESIF3.52022-02-1424OAAI
Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionCLINICAL INFECTIOUS DISEASESIF7.32021-04-2433OAAI
International Niemann-Pick Disease Registry: Establishing worldwide inclusivityMOLECULAR GENETICS AND METABOLISMIF3.52021-02-010PREAI
The International Niemann-Pick Disease Registry (INPDR): A beacon for rare diseasesMOLECULAR GENETICS AND METABOLISMIF3.52020-02-010PREAI
International Niemann-Pick Disease Registry: The characteristics of ASMD and NPC patientsMOLECULAR GENETICS AND METABOLISMIF3.52020-02-010PREAI
Challenges of regulatory requirements for patient registries in different countriesMOLECULAR GENETICS AND METABOLISMIF3.52019-02-010PREAI
Consensus clinical management guidelines for Niemann-Pick disease type CORPHANET JOURNAL OF RARE DISEASESIF3.52018-04-06204OAAI
Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndromeLIVER INTERNATIONALIF5.22016-06-1026OAAI